Evotec grants exclusive rights on EVT 401 in China to Conba Pharmaceutical

Evotec AG and Conba Pharmaceutical Co., Ltd. announced today the grant of a development and marketing license on EVT 401, a selective, small molecule P2X7 antagonist, for human indications with exception of ophthalmological, chronic obstructive pulmonary disease and endometriosis in China. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-grants-exclusive-rights-on-evt-401-in-china-to-conba-pharmaceutical-5053

Weiterlesen

Evotec and Active Biotech Extend and Expand Medicinal Chemistry Collaboration

Evotec AG today announced that it has extended and expanded its medicinal chemistry collaboration with Active Biotech AB, to further advance an existing programme, which has entered the lead optimisation phase. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-and-active-biotech-extend-and-expand-medicinal-chemistry-collaboration-5051

Weiterlesen

Evotec and IR Pharma Establish Drug Discovery Alliance in the Field of Respiratory

Evotec AG and IR Pharma today announced that they have entered into an exclusive strategic alliance to provide integrated drug discovery solutions to Pharmaceutical and Biotech companies in the field of Respiratory Diseases. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-and-ir-pharma-establish-drug-discovery-alliance-in-the-field-of-respiratory-5043

Weiterlesen

Evotec and Harvard University Expand Strategic Alliance into Kidney Disease

Evotec AG today announced a second strategic alliance with Harvard University, this time including Brigham and Women’s Hospital aimed at discovering and developing new biomarkers and treatments in the field of kidney disease. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/evotec-and-harvard-university-expand-strategic-alliance-into-kidney-disease-5039

Weiterlesen